Pluristem Therapeutics Inc. Changes its Name to "Pluri
As of July 26, 2022, Pluri’s stock will trade under the symbol PLURThe new name reflects the Company’s strategy to leverage its innovative 3D cell-based...
Stay updated with breaking news from Nasdaq Psti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As of July 26, 2022, Pluri’s stock will trade under the symbol PLURThe new name reflects the Company’s strategy to leverage its innovative 3D cell-based...
Pluristem Therapeutics Inc. (NASDAQ:PSTI – Get Rating) was the target of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 584,400 shares, a decrease of 23.7% from the March 15th total of 765,900 shares. Based on an average daily volume of 1,420,000 shares, the […]
HAIFA, Israel, March 08, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company (“Pluristem”),...
Collaboration uniquely combines Pluristem’s technological expertise in mass-scale, cost-effective, consistent cell production with Tnuva’s power...
Pluristem Therapeutics Inc. (NASDAQ:PSTI) went up by 21.77% from its latest closing price compared to the recent 1-year high of $9.89. The company’s stock price has collected 0.68% of gains in the last five trading sessions. Press Release reported 7 hours ago that Biotechnology Company Pluristem,